Publications

Albanesi C, Fairchild HR, Madonna S, Scarponi C, De Pità O, Leung DYM, Howell MD. “IL-4 and IL-13 Negatively Regulate TNF-α and IFN-γ Induced β-Defensin Expression Through STAT-6, SOCS-1, and SOCS-3.” Journal of Immunology, 2007: Jul 15; 179(2): 984-92.

Amanna IJ, Slifka MK, Crotty S. “Immunity and immunological memory following smallpox vaccination.” Immunology, 2006; 211: 320-37.

 

Amanna IJ, Slifka MK. “Quantitation of Rare Memory B Cell Populations by Two Independent and Complementary Approaches.” Journal of Immunological Methods, 2006; 317(1-2): 175-85.

Ando T, Matsumoto K, Namiranian S, Yamashita H, Glatthorn H, Kimura M, Dolan B, Lee JJ, Kawakami Y, Jamora C, Kawakami T. “T cells and mast cells are required for allergen/staphylococcal enterotoxin B-induced skin inflammation.” To be submitted to the Journal of Investigative Dermatology.

 

Ando T, Xiao W, Gao P, Namiranian S, Matsumoto K, Tomimori Y, Hong H, Yamashita H, Kimura M, Rafaels NM, Barnes KC, Jamora C, Kawakami Y, Kawakami T. “Phospholipase C-β3 deficiency predisposes to atopic dermatitis-like skin inflammation in a mast cell-dependent manner.” To be submitted to Nature and Immunology.

 

Bankova L, Brummet ME, Paltiel M, McGirt LY, Beck LA “Expression of Neutrophil Chemoattractants and their Receptors in Subjects with Atopic Dermatitis and Psoriasis” Journal of Allergy and Clinical Immunology, 2006; 117(2) S1:S236 (Abstract).

Bankova L, Brummet M, McGirt LY, Hosler G, Beck LA “Expression of Receptors Relevant for Neutrophil Migration in Subjects with Atopic Dermatitis, Psoriasis and Healthy Controls” Journal of Investigative Dermatology, 2006; 126 (1S):A26 (Abstract).

Bankova LG, Brummet ME, Grigoryev DN, Cheadle C, Barnes KC, Leung DY, Beck LA “GM-CSF and NF-κB pathways are dysregulated in neutrophils from atopic dermatitis subjects” Journal of Investigative Dermatology, 2007; 127(S1):S122; abstract 729.

Bankova LG,  Brummet ME, Grigoryev DN, Bochner BS, Barnes KC, Beck LA “GM-CSF Pathway Defects May Account for Reduced Neutrophil Chemotaxis in Atopic Dermatitis” Journal of Allergy and Clinical Immunology, 2007; 119(1): S238; abstract 932.

Beck L, Boguniewicz M,  Hata T, Schneider L, Hanifin J, Gallo R, Paller A, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes K, Leung D. “Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.” Journal of Allergy and Clinical Immunology, 2009; August, 124(2): 260-269.

Bieber T. “Mechanisms of Disease: Atopic Dermatitis.” New England Journal of Medicine, 2008 Apr; 358: 1483-1494.

Bin L, Howell M, Kim BE, Hall CF, Streib J, Leung D. “Inhibition of S100A11 Gene Expression Impairs Keratinocyte Response against Vaccinia Virus through Down-regulation of the IL-10 Receptor 2 chain.” Journal of Allergy and Clinical Immunology, 2009; August, 124(2): 270-277.

Bin L, Howell MD, Kim BE, Streib JE, Leung DYM. “Inhibition of Transcription Factor Specificity Protein 1 Alters the Gene Expression Profile of Keratinocytes Leading to Upregulation of Kallikrein-Related Peptidases and Thymic Stromal Lymphopoietin.” Journal of Investigative Dermatology; 2011 Nov; 131(11): 2213-22.

Bin L, Howell M, Kim B, Streib J, Hall C, Leung D. “Specificity Protein 1 is Pivotal in the Skin’s Antiviral Response.” Journal of Allergy and Clinical Immunology; 2011 Feb; 127(2): 430-438.


Bin L, Kim BE, Brauweiler A, Goleva E, Streib J, Ji Y, Schlievert PM, Leung DY. “Staphylococcus aureus a-toxin modulates skin host response to viral infection.” Journal of Allergy and Clinical Immunology. 2012 September; 130(3): 683-691 (Abstract).

Broccardo C, Mahaffey S, Schwarz J, Wruck L, David G, Schlievert P, Reisdorph N, Leung D. “Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization.” Journal of Allergy and Clinical Immunology; 2011 Jan; 127(1): 186-93, 193.e1-11.

Broccardo CJ, Mahaffey SB, Strand M, Reisdorph NA, Leung DYM. “Peeling off the layers: Skin taping and a novel proteomics approach to study atopic dermatitis.” Journal of Allergy and Clinical Immunology, 2009 Nov; 124(5): 1113-1115.

Bussmann C, Peng W-M, Bieber T, Novak N. “Molecular pathogenesis and clinical implications of eczema herpeticum.” Expert Reviews in Molecular Medicine, 2008: Jul 14; 10:e21.

 

De Benedetto A, Yoshida T, Kuo I, Rafaels N, Boguniewicz, Hata T, Schneider L, Hanifin J, Gallo R, Leung D, Barnes K, Beck L. “Connexin-26 is upregulated in atopic dermatitis epidermis.” Journal of Investigative Dermatology. 2012 May; 132(S1): S51-64 (Abstract).

De Benedetto A, Qualia CM, Baroody FM, and Beck LA. “Filaggrin Expression in Oral, Nasal, and Esophageal Mucosa.” Journal of Investigative Dermatology, 2008: Jan 03; 128: 1594-1597.

De Benedetto A, Slifka M, Rafaels N, Kuo I, Georas S, Boguniewicz M, Hata T, Schneider L, Hanifin J, Gallo R, Paller A, Johnson D, Barnes K, Leung D, Beck L. “Reductions in Claudin-1 may enhance susceptibility to HSV-1 infections in atopic dermatitis.” Journal of Allergy and Clinical Immunology; 2011 Jul; 128(1): 242-246.

De Benedetto A, Kubo A, Beck LA.  “Skin Barrier Disruption – A Requirement for Allergen Sensitization.” Journal of Investigative Dermatology 2012 March; 132: 949-963.

De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger A, Boguniewicz M, Hata T, Schneider LM, Hanifin JM, Gallo RL, Weidinger S, Beaty TH, Leung DY, Barnes KC, Beck LA. “Tight Junction Defects in Patients with Atopic Dermatitis.” Journal of Allergy and Clinical Immunology, 2011 Mar; 127(3): 773-786.

Domenico J, Lucas JJ, Fujita M, Gelfand EW. “Susceptibility to Vaccinia Virus Infection and Spread is Determined by Age at Infection, Allergen Sensitization and Mast Cell Status.” International Archives of Allergy and Immunology, 2012; 158(2): 196-205.

Freyschmidt E-J, Mathias CB, MacArthur DH, Laouar A, Manjunath N, Hofer M, Wurbel M-A, Campbell J, Chatila T, Oettgen HC. “Skin inflammation arising from Cutaneous Treg deficiency leads to Impaired viral immune responses.” Journal of Immunology, 2010 Jul; 185(2): 1295-1302.

Freyschmidt EJ, Mathias CB, MacArthur DH, Laouar A, Narasimhaswamy M, Weih F, Oettgen HC. “Skin inflammation in RelB-/- mice leads to defective immunity and impaired clearance of vaccinia virus.” Journal of Allergy and Clinical Immunology, 2007 March; 119(3): 671-9.

Gao PS, Rafaels NM, Hand T,  Murray T, Boguniewicz M,  Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Barnes KC, Leung DYM. “Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.” Journal of Allergy and Clinical Immunology, 2009 September; 124(3): 507-513.

Gao PS, Leung DY, Rafaels NM, Boguniewicz M, hand T, Gao L, Hata TR, Schneider LC, Hanifin JM, Beaty TH, Beck LA, Weinberg A, Barnes KC. “Genetic Variants in Interferon Regulatory Factor 2 (IRF2) Are Associated with Atopic Dermatitis and Eczema Herpeticum.” Journal of Investigative Dermatology, 2012 March; 132 (3 Pt 1): 650-7.

Gao PS, Rafaels NM, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck L, Leung DYM, Barnes KC. “Genetic Variants in TSLP and its Receptor, IL7R, Contribute to an Increased Risk for Atopic Dermatitis and Eczema Herpeticum.” Journal of Allergy and Clinical Immunology, 2009; February, 123(2): S70 (Abstract).

Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Leung DYM, Barnes KC. “Genetic variants in TSLP are associated with atopic dermatitis and eczema herpeticum.” Journal of Allergy and Clinical Immunology, 2010 June; 125(6): 1403-1407.

Grigoryev DN, Howell MD, Watkins T, Chen Y-C, Cheadle C, Boguniewicz M, Barnes KC, Leung DY. “Vaccinia Virus-Specific Molecular Signature in Atopic Dermatitis Skin.” Journal of Allergy and Clinical Immunology, 2010 January; 125(1): 153-159.

Hammarlund E, Lewis MW, Hanifin J, Simpson EL, Carlson NE, Slifka MK. “Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment.” Vaccine, 2008: Jan 17; 26(3): 430-439.

Hata T, Kotol P, Kabigting F, Miller J, Alexandrescu D, Boguniewicz M, Taylor P, Aertker L, Kesler K, Hanifin J, Leung DYM, Gallo RL. “A Randomized Controlled Double Blind Investigation of the Effects of Vitamin D Dietary Supplementation in Subjects with Atopic Dermatitis.” Submitted: The British Journal of Dermatology

Hata T, Kotol P, Boguniewicz M, Taylor P, Paik A, Jackson M, Nguyen M, Kabigting F, Miller J, Gerber M, Zaccaro D, Armstrong B, Dorschner R,  Leung DY, Gallo RL. “History of Eczema Herpeticum is associated with the inability to induce HBD-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis.” The British Journal of Dermatology; 2010 Sep; 163(3): 659-661.

He R, Kim HY, Yoon J, Oyoshi MK, MacGinnitie A, Goya S, Freyschmidt EJ, Bryce P, McKenzie AN, Umetsu DT, Oettgen HC, and Geha RS. “Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.” Journal of Allergy and Clinical Immunology, 2009 Oct; 124(4): 761-770.

He R, Oyoshi MK, Wang JYT, Hodge MR, Jin H, and Geha RS. “The prostaglandin D2 receptor CRTH2 is important for allergic skin inflammation following epicutaneous antigen challenge.” Journal of Allergy and Clinical Immunology; 2010 Oct; 126(4): 784-790.

He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS. “TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.” Proceedings of the National Academy of Sciences, 2008 Aug; 105(33): 11875-11880.

Hinz T, Zaccaro D, Byron M, Brendes K, Krieg T, Novak N, Bieber T. “Atopic Dermo-Respiratory Syndrome Is a Correlate of Eczema Herpeticum.” Allergy; 2011 Jul; 66(7): 925-33.

Howell MD, Streib J, Leung DYM. “Anti-Viral Activity of Human β-Defensin 3 Against Vaccinia Virus.” Journal of Allergy and Clinical Immunology, 2007; 119(4): 1022-1025.

Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, Pavicic T, Boguniewicz M, Leung DYM. “Cathelicidin Deficiency Predisposes to Eczema Herpeticum.” Journal of Allergy and Clinical Immunology, 2005; 117(4): 836-41.

Howell MD, Streib JE, Kim BE, Lesley L, Dunlap A, Geng D, Savage PB, Leung DYM. “Ceragenins: A Class of Antiviral Compounds to Treat Orthopox Infections.” Journal of Investigative Dermatology, 2009; November 129: 2668-2675.

Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, Leung DYM. “Cytokine Milieu of Atopic Dermatitis Skin Subverts the Innate Immune Response to Vaccinia Virus.” Immunity, 2006; 24(5): 341-348.

Howell MD, Kim BE, Gao P, Grant A, Boguniewicz M, DeBendetto A, Beck LA, Barnes KC, Leung DYM. “Cytokine modulation of atopic dermatitis filaggrin skin expression.” Journal of Allergy and Clinical Immunology, 2007; 120(1): 150-155.

Howell M, Gao P, Kim B, Lesley L, Streib J, Taylor P, Zaccaro D, Boguniewicz M, Beck L, Hanifin J, Schneider L, Hata T, Gallo R, Kaplan M, Barnes K, Leung D. “The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.” Journal of Allergy and Clinical Immunology; 2011 Nov; 128(5): 1006-14.

Howell MD, Fairchild H, Kim BE, Bin L, Boguniewicz M, Redzic JS, Hansen KC, Leung DYM. “Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation.” Journal of Investigative Dermatology, 2008: Apr 03; 128: 2248-2258.

Jin H, Oyoshi M, He R, Geha RS. “Animal models of atopic dermatitis.” Journal of Investigative Dermatology, 2009 Jan; 129: 31-40.

Jin H, Oyoshi M, Le Y, Bianchi T, Koduru S, Mathias BC, Kumar L, Le Bras S, Young D, Collins M, Grusby MJ, Wenzel J, Bieber T, Boes M, Silberstein LE, Oettgen H, Geha R. “IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice.” Journal of Clinical Investigation, 2009 Jan 05; 119(1): 47-60.

Jin H, Kumar L, Mathias C, Zurakowski D, Oettgen H, Gorelik L, Geha R. “Toll-like receptor 2 is important for the Th1 response to cutaneous sensitization.” Journal of Allergy and Clinical Immunology, 2009 Apr; 123(4): 875-882.

Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y. “Mast cells in atopic dermatitis.” Current Opinion in Immunology, 2009 Dec; 21(6):666-678.

Kawakami Y, Tomimori Y, Yumoto K, Hasegawa S, Ando T, Tagaya Y, Crotty S, Kawakami T. “Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.” Journal of Experimental Medicine, 2009 June; 206: 1219-1225.

Kim BE, Bin L, Leung DYM. “IL-25 Enhances HSV-1 Replication by Inhibiting Filaggrin Expression, and Acts Synergistically with TH2 Cytokines to Enhance HSV-1 Replication.”  Submitted to Journal of Investigative Dermatology.

Kim BE, Leung DYM, Boguniewicz M, Howell MD. “Loricrin and Involucrin Expression is Down-Regulated by Th2 Cytokines Through STAT-6.” Clinical Immunology, 2008 Mar; 126: 332-337.

Kim BE, Leung DYM, Streib JE, Boguniewicz M, Hamid QA, Howell MD. “Macrophage Inflammatory Protein 3a Deficiency in Atopic Dermatitis Skin and Role in Innate Immune Response to Vaccinia Virus.” Journal of Allergy and Clinical Immunology, 2007 Feb; 119(2): 457-63.

Kumar L, Geha RS. “C3a Receptor (C3aR) is Important for Viral Containment in Mice Inoculated with Vaccinia Virus (VV) at Sites of Allergic Skin Inflammation” Journal of Allergy and Clinical Immunology. 2012 February; 129(2): AB37. (Abstract).

Kuo IH, Yoshida T, Rafaels NM, Behrendt M, McGirt LY, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Borkowski AW, Yamasaki K, Barnes KC, Georas SN, Gallo RL, Leung DY, De Benedetto A, Beck LA. “Epidermal toll-like receptor 2 activation enhances tight Junction function and this effect may be reduced in subjects with atopic dermatitis.” Accepted by the Journal of Investigative Dermatology.

Leisten S, Oyoshi MK, Hornick JL, Geha RS. “Development of skin lesions in filaggrin-deficient mice is dependent on adaptive immunity.” Letter to the Editor to be submitted to the Journal of Allergy and Clinical Immunology.

 

Leung D, Gao P, Grigoryev D, Rafaels N, Strieb J, Howell M, Taylor P, Boguniewicz M, Canniff J, Armstrong B, Zaccaro D, Schneider L, Hata T, Hanifin J, Beck L, Weinberg A, Barnes K. “Human Atopic Dermatitis Complicated by Eczema Herpeticum is Associated with Abnormalities in Gamma Interferon Response.” Journal of Allergy and Clinical Immunology; 2011 Apr; 127(4): 965-73.

 

Li G, Domenico J, Jia Y, Lucas JJ, and Gelfand EW. “NF-κB-Dependent Induction of Cathelicidin-Related Antimicrobial Peptide (CRAMP) in Murine Mast Cells by Lipopolysaccharide.” International Archives of Allergy and Immunology, 2009 Sep; 150(2): 122-132.

Liu L, Fuhlbrigge RC, Karibian K, Tian T, Kupper TS. “Dynamic programming of CD8+ T cell trafficking after live viral immunization.” Immunity, 2006 Sep; 25(3): 511-20.

Liu L, Zhong Q, Tian T, Dubin K, Athale SK, Kupper TS. “Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity.” Nature Medicine; 2010 Feb; 16(2):224-7.

Mathias RA, Weinberg A, Boguniewicz M, Zaccaro DJ, Armstrong B, Schneider LC, Hata TR, Hanifin JM, Beck LA, Barnes KC, Leung DYM. “Atopic Dermatitis Complicated by Eczema Herpeticum is Associated with HLA B7 and Reduced Gamma Interferon Producing CD8+ T Cells.” British Journal of Dermatology.

McGirt LY, Beck LA. “Innate Immune Defects in Atopic Dermatitis.” Journal of Allergy and Clinical Immunology, 2006; 118: 202-8.

Milgrom H, Kesler K, Byron M, Harbeck R, Holliday R, Leung DYM. “Response to cutaneous immunization with low molecular weight subunit keyhole limpet hemocyanin (KLH).” International Archives of Allergy and Immunology; 2011 Oct 28; 157(3): 269-274.

Muehleisen B, Bickle DD, Aguilera C, Burton DW, Deftos LJ, Gallo RL. “Vitamin D and PTH/PTHrP alter antimicrobial expression and susceptibility to bacterial skin infection.” Science Translational Medicine. 2012 May 23; 4(135): 135ra66.

Oyoshi MK, He R, Kumar L, Yoon J, Geha RS. “Cellular and molecular mechanisms in Atopic dermatitis.”

Advances in Immunology; 2009; 102:135-226.

Oyoshi MK, ElKhal A, Scott JE, Wurbel M, Hornick JL, Campbell JJ, and Geha RS. “Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin.” Journal of Clinical Investigation; 2011 Jun; 121(6): 2210-2220.

Oyoshi MK, Murphy GF, Geha RS. “Filaggrin deficient mice exhibit Th17-dominated skin inflammation and permissiveness to contact sensitization with protein antigen.” Journal of Allergy and Clinical Immunology, 2009 Sep; 124(3): 485-493.

Oyoshi MK, Wang JYT, and Geha RS. “Immunization with modified vaccinia virus Ankara prevents eczema vaccinatum in a murine model of atopic dermatitis.” Journal of Allergy and Clinical Immunology; 2011 Oct; 128(4): 890-892.

Oyoshi MK, He R, Li Y, Mondal S, Yoon J, Afshar R, Chen M, Lee DM, Luo HR, Luster AD, Cho JS, Miller LS, Larson A, Murphy GF, Geha RS. “Leukotriene B4 Driven Neutrophil Recruitment to the Skin is Essential for Allergic Skin Inflammation.” To be submitted to Immunity.

Oyoshi MK, Larson RP, Ziegler SF, and Geha RS. “Mechanical injury polarizes skin dendritic cells to elicit a Th2 response by inducing cutaneous TSLP expression.” Journal of Allergy and Clinical Immunology; 2010 Nov; 126(5): 976-984.

Oyoshi MK, Ramesh N, Geha RS. “Vaccinia immune globulin ameliorates eczema vaccinatum in a murine model of atopic dermatitis.” Journal of Investigative Dermatology  2012 April; 132(4): 1299-301.

Oyoshi MK, Elkhal A, Kumar L, Scott JE, Koduru S, He R, Leung DY, Howell MD, Oettgen HC, Murphy GF, Geha RS. “Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.” Proceedings of the National Academy of Sciences, 2009 Sep; 106(35): 14954-14959.

Peng W-M, Yu C-F,  Allama J-P, Oldenburg J, Bieber T, Hoch J, Eis-Hübinger A-M, Novak N. “Inhibitory oligodeoxynucleotides downregulate herpes simplex virus-induced plasmacytoid dendritic cell type I interferon production and modulate cell function.” Human Immunology, 2007: Nov; 68(11): 879-87.

Peng W, Jenneck C, Bussmann C, Hart J, Leung DYM, Bieber T, Eis-Hübinger AM, Novak N. “Risk factors of atopic dermatitis patients for eczema herpeticum.” Journal of Investigative Dermatology, 2007; 127(5): 1261-3.

Schauber J, Dorschner R, Yamasaki K, Brouha B, Gallo RL. “Control of the innate antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli.” Immunology, 2006; 118(4): 509-19.

Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zügel U, Bikle DD, Modlin RL, Gallo RL. “Injury enhances TLR2 function and antimicrobial peptide expression through a Vitamin D dependent mechanism.” Journal of Clinical Investigation, 2007; 117(3): 803-81.

Schlievert PM, Case LC, Strandberg KL, Abrams BB, Leung DYM. “Superantigen Profile of Staphylococcus aureus Isolates from Patients with Steroid-Resistant Atopic Dermatitis.” Clinical Infectious Diseases, 2008; May 15; 46(10): 1562-1567.

Schneider L, Weinberg A, Boguniewicz M, Taylor P, Oettgen H, Heughan L, Zaccaro D, Armstrong B, Holliday A, Leung DYM. “Immune response to Varicella vaccine in children with atopic dermatitis compared to non-atopic controls.” Journal of Allergy and Clinical Immunology, 2010 Dec; 126(6); 1306-13-7.

Scott JE,  Elkhal A, Freyschmidt E, MacArthur DH, McDonald D, Howell MD, Leung DYM, Laouar A, Manjunath N, Bianchi T, Boes M, Oettgen HC, Geha RS. “Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation.” Journal of Allergy and Clinical Immunology, 2007 Dec; 120(6):1382-1388.

Slifka MK, Leung DYM, Hammarlund E, Raue HP, Simpson EL, Tofte S, Baig-Lewis S, David G, Lynn H, Woolson R, Hata T, Milgrom H, Jon Hanifin J. “transcutaneous yellow fever vaccination reveals differences in immune responsiveness between non-atopic subjects and patients with atopic dermatitis.”

Tian T, Liu L, Freyschmidt E-J, Murphy GF, Kupper TS, Fuhlbrigge RC. “Overexpression of IL-1α in skin differentially modulates the immune response to scarification with vaccinia virus.” Journal of Investigative Dermatology, 2009 Jan; 129: 70-78.

Yamasaki K, Schauber J, Coda A, Lin H, Dorschner R, Schechter N, Bonnart C, Descargues P, Havnanian A, Gallo RL. “Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidin in skin.” The Journal of the Federation of American Societies for Experimental Biology, 2006; 20: 2060-80.

 



National Jewish Health

Boston Children's Hospital

Children's Hospital Los Angeles

Northwestern University

Oregon Health & Science University

University of Rochester Medical Center

Learn More

Contact the site nearest you or call our toll-free number at 1.888.413.5852 to learn more about participation.